Skip to main content
Cambridge Centre for Parkinson-Plus
Menu
Search
Home
Introduction
People
Scientific Discovery
Clinical Translation
Links
News
Events
More
Home
Introduction
People
Scientific Discovery
Clinical Translation
Links
News
Events
Search
Introduction
Introduction overview
What are Parkinson-Plus Syndromes?
Who are we?
Participation
Contact us
People
People overview
Principal Investigators
Post-doctoral Scientists
Graduate Students
Research Nurses
Research Assistants
Support Staff
Affiliated researchers and staff members
Alumni
Scientific Discovery
Scientific Discovery overview
Programme 1: Trazodone
Programme 2: Synucleinopathies
Programme 3: Genetic mutations
Clinical Translation
Clinical Translation overview
Programme 1: Mechanisms/Heterogeneity
Clinical Trial A: Noradrenergic therapy
Clinical Trial B: Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD)
Clinical Trial C: UPR signalling/Trazodone
Events
Events overview
Past Events
Menu
Home
Introduction
People
Scientific Discovery
Clinical Translation
Links
News
Events
Introduction
Introduction overview
What are Parkinson-Plus Syndromes?
Who are we?
Participation
Contact us
People
People overview
Principal Investigators
Post-doctoral Scientists
Graduate Students
Research Nurses
Research Assistants
Support Staff
Affiliated researchers and staff members
Alumni
Scientific Discovery
Scientific Discovery overview
Programme 1: Trazodone
Programme 2: Synucleinopathies
Programme 3: Genetic mutations
Clinical Translation
Clinical Translation overview
Programme 1: Mechanisms/Heterogeneity
Clinical Trial A: Noradrenergic therapy
Clinical Trial B: Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD)
Clinical Trial C: UPR signalling/Trazodone
Events
Events overview
Past Events
Search
Submit
Home
News
News
Back to top
